View in EDS

Long-term outcomes after adjuvant treatment of sequential versus combination docetaxel with doxorubicin and cyclophosphamide in node-positive breast cancer: BCIRG-005 randomized trial.

Saved in:
Bibliographic Details
Title: Long-term outcomes after adjuvant treatment of sequential versus combination docetaxel with doxorubicin and cyclophosphamide in node-positive breast cancer: BCIRG-005 randomized trial.
Authors: Mackey, J. R.1 john.mackey@trioncology.org, Pieńkowski, T.2, Crown, J.3, Sadeghi, S.4, Martin, M.5, Chan, A.6, Saleh, M.7, Sehdev, S.8, Provencher, L.9, Semiglazov, V.10, Press, M. F.11, Sauter, G.12, Lindsay, M.13, Houé, V.14, Buyse, M.15, Drevot, P.14, Hitier, S.16, Bensfia, S.16, Eiermann, W.17
Source: Annals of Oncology. Jun2016, Vol. 27 Issue 6, p1041-1047. 7p. 2 Charts, 1 Graph.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1093/annonc/mdw098